EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA

Ichiro Taniguchi iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0312098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ichiro Taniguchi. Beteiligte Einrichtung: Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Active Transport, Cell Nucleus, RNA, Messenger, SARS-CoV-2, Spliceosomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shimizu Foundation for Immunology and Neuroscience, Kao Research Council for the Study of Healthcare Science, Fujiwara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19). SARS-CoV-2 infection suppresses host innate immunity and impairs cell viability. Among the viral proteins, ORF6 exhibits potent interferon (IFN) antagonistic activity and cellular toxicity. It also interacts with the RNA export factor RAE1, which bridges the nuclear pore complex and nuclear export receptors, suggesting an effect on RNA export. Using the Xenopus oocyte microinjection system, I found that ORF6 blocked the export of not only mRNA but also spliceosomal U snRNA. I further demonstrated that ORF6 affects the interaction between RAE1 and nuclear export receptors and inhibits the RNA binding of RAE1. These effects of ORF6 may cumulatively block the export of several classes of RNA. I also found that ORF6 binds RNA and forms oligomers. These findings provide insights into the suppression of innate immune responses and the reduction in cell viability caused by SARS-CoV-2 infection, contributing to the development of antiviral drugs targeting ORF6.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Active Transport, Cell NucleusRNA, MessengerSARS-CoV-2SpliceosomesRNA, Small NuclearNucleocytoplasmic Transport ProteinsAnimalsHumansViral ProteinsCOVID-19Nuclear Matrix-Associated ProteinsXenopus laevisOocytes

Substanzen

RNA, MessengerRNA, Small NuclearORF6 protein, SARS-CoV-2Nucleocytoplasmic Transport ProteinsViral ProteinsRAE1 protein, humanNuclear Matrix-Associated Proteins

Autor:innen und Institutionen

  • Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.

ORCID-Profile: Ichiro Taniguchi

Förderung

  • Shimizu Foundation for Immunology and Neuroscience
  • Kao Research Council for the Study of Healthcare Science
  • Fujiwara Memorial Foundation
  • Japan Society for the Promotion of Science
  • LiMe Office of Director's Research Grants Program

Zitieren

APA

Taniguchi, I. (2024). The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA. PLOS ONE. https://doi.org/10.1371/journal.pone.0312098

Vancouver

Taniguchi I. The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA. PLOS ONE. 2024. doi:10.1371/journal.pone.0312098

BibTeX
@article{Taniguchi2024,
  author = {Taniguchi, Ichiro},
  title = {The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0312098}
}
Kostenlos starten →